Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts.

Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community.

Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report.

{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium.

Ocular Manifestations in Primary Immunodeficiency Disorders: A Report from the United States Immunodeficiency Network (USIDNET) Registry.

Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease.

Leah Witt Gives Advance Care Planning Presentation

Leah Witt, MD gave a presentation about advance care planning at the Pulmonary Ambulatory virtual meeting on 3/27 and at the entire Division of Pulmonary & Critical Care virtual meeting on 3/30. She created this presentation with Rebecca Sudore, MD, and the primary goal was to encourage outpatient providers to focus on ACP in upcoming visits, which is particularly critical during the COVID-19 pandemic. The presentation directed providers to the PREPARE COVID-19 website, with communication tools, tip sheets, and language for providers specific to advance care planning during the COVID-19 pandemic.

Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference?

Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines.

The strongest Brønsted acid: protonation of alkanes by H(CHB(11)F(11)) at room temperature.

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

Development of and recovery from difficulty with activities of daily living: an analysis of national data.

Distinct myocardial lineages break atrial symmetry during cardiogenesis in zebrafish.

Factors Associated With Discontinuation of Subspecialty Diabetes Care During the COVID-19 Pandemic: A Multisite Retrospective Cohort Study.

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.